Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in

Sebastian Uhl1, Ilka Mathar2, Rudi Vennekens3

  • 1Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, D-69120 Heidelberg, Germany.

Insights

TRPM4 deficiency enhances heart muscle contraction, particularly under ATP-depleting conditions like ischemia. Inactivating TRPM4 may boost cardiac contractility in heart failure and related conditions.

Area of Science:

  • Cardiovascular Physiology
  • Ion Channel Function
  • Molecular Cardiology

Background:

  • TRPM4 and TRPM5 are Transient Receptor Potential (TRP) ion channels forming Ca(2+)-activated nonselective cation channels.
  • TRPM4 deficiency (Trpm4(-/-)) previously showed increased Isoprenaline-induced inotropy due to faster action potential repolarization.
  • The role of TRPM4 and TRPM5 in cardiac contractility, especially under stress, requires further investigation.

Purpose of the Study:

  • To investigate the contribution of the β-adrenergic signaling cascade to augmented inotropy in TRPM4-deficient mice.
  • To determine if TRPM5 additively affects cardiac contractility using double-deficient (Trpm4/Trpm5((-/-)2)) mice.
  • To explore TRPM4's role in cardiac contractility under ATP-depleting conditions.

Main Methods:

  • Contractility measurements on isolated papillary muscles from wild type, Trpm4(-/-), and Trpm4/Trpm5((-/-)2) mice.
  • Stimulation with Isoprenaline, Forskolin (adenylyl cyclase activator), and IBMX (phosphodiesterase inhibitor).
  • Assessment of cardiac function under simulated ischemic conditions.

Main Results:

  • Isoprenaline-induced inotropy was significantly increased in Trpm4(-/-) and Trpm4/Trpm5((-/-)2) mice compared to wild type.
  • Forskolin also increased twitch force in Trpm4(-/-) preparations, but cAMP levels were comparable to wild type.
  • TRPM4 deficiency improved contractile function under simulated ischemic conditions, suggesting a role in ATP-depleting states.

Conclusions:

  • TRPM4 deficiency enhances cardiac contractility, particularly during conditions of increased catecholamine levels and ATP depletion.
  • The augmented inotropic response in TRPM4-deficient hearts is not solely due to altered cAMP accumulation but is linked to ATP hydrolysis.
  • TRPM4 inactivation presents a potential therapeutic strategy for increasing cardiac contractility in conditions like heart failure and ischemia.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
2.7K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.8K